Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950137-04-003818
Filing Date
2004-05-10
Accepted
2004-05-10 14:12:08
Documents
6
Period of Report
2004-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q PERIOD ENDED MARCHE 31, 2004 a98765e10vq.htm 10-Q 618177
2 EXHIBIT 15.1 a98765exv15w1.htm EX-15.1 2900
3 EXHIBIT 15.2 a98765exv15w2.htm EX-15.2 1658
4 EXHIBIT 31.1 a98765exv31w1.htm EX-31.1 5074
5 EXHIBIT 31.2 a98765exv31w2.htm EX-31.2 5038
6 EXHIBIT 32.1 a98765exv32w1.htm EX-32.1 3284
  Complete submission text file 0000950137-04-003818.txt   638415
Mailing Address 3300 HYLAND AVE COSTA MESA CA 92626
Business Address 3300 HYLAND AVE COSTA MESA CA 92626 7145450100
VALEANT PHARMACEUTICALS INTERNATIONAL (Filer) CIK: 0000930184 (see all company filings)

EIN.: 330628076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-11397 | Film No.: 04792272
SIC: 2834 Pharmaceutical Preparations